| Not Yet Recruiting | Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone NCT07038408 | Ceric Sàrl | N/A |
| Not Yet Recruiting | Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patie NCT07454070 | Jing Han | N/A |
| Not Yet Recruiting | Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With NCT07374718 | Shenyang Northern Hospital | N/A |
| Not Yet Recruiting | Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet NCT07354828 | Shenyang Northern Hospital | — |
| Not Yet Recruiting | Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction NCT07077057 | Cardiocentro Ticino | N/A |
| Not Yet Recruiting | Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK) NCT06736665 | Spanish Society of Cardiology | Phase 4 |
| Not Yet Recruiting | Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome NCT06723002 | University of Monastir | Phase 2 / Phase 3 |
| Recruiting | RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial NCT06449274 | Harbin Medical University | N/A |
| Recruiting | Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) NCT06365502 | Harbin Medical University | N/A |
| Unknown | OPTImal Management of Antithrombotic Agents: OPTIMA-5 NCT04116931 | The First Affiliated Hospital with Nanjing Medical University | Phase 4 |
| Unknown | Implementing Precision Medicine Approaches to Guide Anti-platelet Selection NCT04090281 | University of Southern California | Phase 4 |
| Completed | Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary I NCT03672097 | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | Phase 4 |
| Unknown | VITROS Immunodiagnostic Products hs Troponin I NCT03581578 | Ortho-Clinical Diagnostics, Inc. | — |
| Unknown | Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPT NCT03234114 | The First Affiliated Hospital with Nanjing Medical University | Phase 4 |
| Completed | The Effect of IV Cangrelor and Oral Ticagrelor Study NCT02733341 | The Royal Wolverhampton Hospitals NHS Trust | Phase 4 |
| Completed | Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients NCT02430493 | AstraZeneca | — |
| Completed | EndoTic - Endothelium and Ticagrelor NCT02244710 | Fundación Investigación Sanitaria en León | N/A |
| Completed | Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Vo NCT02286544 | Karolinska Institutet | Phase 1 |
| Completed | Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers NCT02290080 | Karolinska Institutet | Phase 3 |
| Completed | Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes NCT02265068 | IHF GmbH - Institut für Herzinfarktforschung | — |
| Completed | Effect of Perioperative Clopidogrel Responsiveness on Ischemic Outcome in Patients With Acute Coronary Syndrom NCT02184884 | Yonsei University | — |
| Completed | PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial. NCT02171065 | Uppsala University | N/A |
| Completed | Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome NCT01944800 | Deutsches Herzzentrum Muenchen | Phase 4 |
| Completed | Optimum Troponin Cutoffs for ACS in the ED NCT01994577 | Canadian Institutes of Health Research (CIHR) | — |
| Unknown | Platelet Function in Patients With an Acute Coronary Syndrome NCT01992484 | Medical University of Vienna | — |
| Completed | Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of NCT01405287 | OrbusNeich | Phase 2 |
| Completed | Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Interventi NCT01109784 | University of Patras | Phase 3 |
| Completed | A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome NCT00932100 | Regado Biosciences, Inc. | Phase 2 |
| Completed | Maintenance of Platelet Inhibition With Cangrelor NCT00767507 | The Medicines Company | Phase 2 |
| Completed | Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome NCT00855257 | French Cardiology Society | Phase 3 |
| Completed | Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Pr NCT00415948 | Abbott RDx Cardiometabolic | — |
| Completed | Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes NCT00399880 | Vanderbilt University Medical Center | N/A |
| Terminated | Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. NCT00385138 | The Medicines Company | Phase 3 |
| Completed | Safety Study of Apixaban in Recent Acute Coronary Syndrome NCT00313300 | Bristol-Myers Squibb | Phase 2 |
| Terminated | A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease NCT00208117 | New York State Psychiatric Institute | Phase 1 |
| Unknown | Essential Hypotension and Allostasis Registry NCT02018497 | CES University | — |